Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study
the Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol (AMP) study
Fingerprint
Dive into the research topics of 'Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study'. Together they form a unique fingerprint.